Induction of p27 contributes to inhibitory effect of isorhapontigenin (ISO) on malignant transformation of human urothelial cells

References

• Huang KS, Wang YH, Li RL, et al. Stilbene dimers from the lianas of gnetum hainanense. Phytochemistry. 2000;54(8):875–881.
   PubMed Web of Science ®Google Scholar
• Zeng X, Xu Z, Gu J, et al. Induction of miR-137 by isorhapontigenin (ISO) directly targets sp1 protein translation and mediates its anticancer activity both in vitro and in vivo. Mol Cancer Ther. 2016;15(3):512–522.
   PubMed Web of Science ®Google Scholar
• Fang Y, Cao Z, Hou Q, et al. Cyclin d1 downregulation contributes to anticancer effect of isorhapontigenin on human bladder cancer cells. Mol Cancer Ther. 2013;12(8):1492–1503.
   PubMed Web of Science ®Google Scholar
• Xu Z, Zeng X, Xu J, et al. Isorhapontigenin suppresses growth of patient-derived glioblastoma spheres through regulating mir-145/sox2/cyclin d1 axis. Neuro Oncol. 2016;18(6):830–839.
   PubMed Web of Science ®Google Scholar
• Jiang G, Wu AD, Huang C, et al. Isorhapontigenin (ISO) inhibits invasive bladder cancer formation in vivo and human bladder cancer invasion in vitro by targeting STAT1/FOXO1 axis. Cancer Prev Res (Phila). 2016;9(7):567–580. 10.1158/1940-6207.CAPR-15-0338.
   PubMed Web of Science ®Google Scholar
• Sharma SS, Pledger WJ. The non-canonical functions of p27 Kip1 in normal and tumor biology. Cell Cycle. 2016;15(9):1189–1201.
   PubMed Web of Science ®Google Scholar
• Polyak K, Lee M-H, Erdjument-Bromage H, et al. Cloning of p27kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell. 1994;78(1):59–66.
   PubMed Web of Science ®Google Scholar
• Slingerland J, Pagano M. Regulation of the cdk inhibitor p27 and its deregulation in cancer. J Cell Physiol. 2000;183(1):10–17.
   PubMed Web of Science ®Google Scholar
• Lee J, Kim SS. The function of p27 KIP1 during tumor development. Exp Mol Med. 2009;41(11):765.
   PubMed Web of Science ®Google Scholar
• Viglietto G, Motti ML, Bruni P, et al. Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27 kip1 by pkb/akt-mediated phosphorylation in breast cancer. Nat Med. 2002;8(10):1136.
   PubMed Web of Science ®Google Scholar
• Sgambato A, Cittadini A, Faraglia B, et al. Multiple functions of p27kip1 and its alterations in tumor cells: a review. J Cell Physiol. 2000;183(1):18–27.
   PubMed Web of Science ®Google Scholar
• Shiu SY, Leung WY, Tam CW, et al. Melatonin mt1 receptor‐induced transcriptional up‐regulation of p27kip1 in prostate cancer antiproliferation is mediated via inhibition of constitutively active nuclear factor kappa b (nf‐κb): potential implications on prostate cancer chemoprevention and therapy. J Pineal Res. 2013;54(1):69–79.
   PubMed Web of Science ®Google Scholar
• Bencivenga D, Caldarelli I, Stampone E, et al. P27kip1 and human cancers: a reappraisal of a still enigmatic protein. Cancer Lett. 2017;403:354–365.
   PubMed Web of Science ®Google Scholar
• Jiang G, Huang C, Li J, et al. Transcriptional and post-transcriptional upregulation of p27 mediates growth inhibition of isorhapontigenin (iso) on human bladder cancer cells. Carcinogenesis. 2018;39(3):482–492.
   PubMed Web of Science ®Google Scholar
• Zhu J, Li Y, Tian Z, et al. Atg7 overexpression is crucial for tumorigenic growth of bladder cancer in vitro and in vivo by targeting the ets2/mirna196b/foxo1/p27 axis. Mol Ther Nucleic Acids. 2017;7:299–313.
   PubMedGoogle Scholar
• Fang Y, Wang Y, Wang Y, et al. A new tumour suppression mechanism by p27kip1: egfr down-regulation mediated by jnk/c-jun pathway inhibition. Biochem J. 2014;463(3):383–392.
   PubMedGoogle Scholar
• Jin H, Xie Q, Guo X, et al. P63alpha protein up-regulates heat shock protein 70 expression via e2f1 transcription factor 1, promoting wasf3/wave3/mmp9 signaling and bladder cancer invasion. J Biol Chem. 2017;292(38):15952–15963.
   PubMed Web of Science ®Google Scholar
• Jin H, Xu J, Guo X, et al. Xiap ring domain mediates mir-4295 expression and subsequently inhibiting p63alpha protein translation and promoting transformation of bladder epithelial cells. Oncotarget. 2016;7(35):56540–56557.
   PubMedGoogle Scholar
• Ouyang W, Ma Q, Li J, et al. Cyclin D1 Induction through IκB kinase β/nuclear factor-κB pathway is responsible for arsenite-induced increased cell cycle g1-S phase transition in human keratinocytes. Cancer Res. 2005;65(20):9287–9293.
   PubMed Web of Science ®Google Scholar
• Liu J, Zhang D, Mi X, et al. P27 suppresses arsenite-induced hsp27/hsp70 expressions through inhibiting jnk2/c-jun-and hsf-1-dependent pathways. J Biol Chem. 2010;285(34):26058–26065.
   PubMed Web of Science ®Google Scholar
• Huang C, Zeng X, Jiang G, et al. Xiap bir domain suppresses mir-200a expression and subsequently promotes egfr protein translation and Anchorage-independent growth of bladder cancer cell. J Hematol Oncol. 2017;10(1):6.
   PubMedGoogle Scholar
• Guo X, Huang H, Jin H, et al. Iso, via upregulating mir-137 transcription, inhibits gsk3β-hsp70-mmp-2 axis, resulting in attenuating urothelial cancer invasion. Mol Ther Nucleic Acids. 2018;12:337–349.
   PubMedGoogle Scholar
• Hua X, Xu J, Deng X, et al. New compound chla-f induces autophagy-dependent anti-cancer effect via upregulating sestrin-2 in human bladder cancer. Cancer Lett. 2018;436:38–51.
   PubMed Web of Science ®Google Scholar
• Yeung C, Dinh T, Lee J. The health economics of bladder cancer: an updated review of the published literature. Pharmacoeconomics. 2014;32(11):1093–1104.
   PubMed Web of Science ®Google Scholar
• Wang QL, Lin M, Liu GT. Antioxidative activity of natural isorhapontigenin. Jpn J Pharmacol. 2001;87(1):61–66.
   PubMedGoogle Scholar
• Fang Y, Yu Y, Hou Q, et al. The Chinese herb isolate isorhapontigenin induces apoptosis in human cancer cells by down-regulating overexpression of antiapoptotic protein xiap. J Biol Chem. 2012;287(42):35234–35243.
   PubMed Web of Science ®Google Scholar
• Yeo SCM, Fenwick PS, Barnes PJ, et al. Isorhapontigenin, a bioavailable dietary polyphenol, suppresses airway epithelial cell inflammation through a corticosteroidindependent mechanism. Br J Pharmacol. 2017;174(13):2043–2059.
   PubMed Web of Science ®Google Scholar
• Dai Y, Yeo SCM, Barnes PJ, et al. Pre-clinical pharmacokinetic and metabolomic analyses of isorhapontigenin, a dietary resveratrol derivative. Front Pharmacol. 2018;9:753.
   PubMed Web of Science ®Google Scholar
• Ankasha SJ, Shafiee MN, Wahab NA, et al. Post-transcriptional regulation of micrornas in cancer: from prediction to validation. Oncol Rev. 2018;12(1):344.
   PubMed Web of Science ®Google Scholar
• Chu IM, Hengst L, Slingerland JM. The cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy. Nat Rev Cancer. 2008;8(4):253.
   PubMed Web of Science ®Google Scholar
• Baffa R, Letko J, McClung C, et al. Molecular genetics of bladder cancer: targets for diagnosis and therapy. J Exp Clin Cancer Res. 2006;25:145–160.
   PubMed Web of Science ®Google Scholar
• Hnit SST, Xie C, Yao M, et al. P27kip1 signaling: transcriptional and post-translational regulation. Int J Biochem Cell Biol. 2015;68:9–14.
   PubMed Web of Science ®Google Scholar
• Dijkers PF, Medema RH, Pals C, et al. Forkhead transcription factor FKHR-L1 modulates cytokine-dependent transcriptional regulation of p27 KIP1. Mol Cell Biol. 2000;20(24):9138–9148.
   PubMed Web of Science ®Google Scholar
• Yang W, Shen J, Wu M, et al. Repression of transcription of the p27(kip1) cyclin-dependent kinase inhibitor gene by c-myc. Oncogene. 2001;20(14):1688–1702.
   PubMed Web of Science ®Google Scholar
• Nahle Z, Polakoff J, Davuluri RV, et al. Direct coupling of the cell cycle and cell death machinery by e2f. Nat Cell Biol. 2002;4(11):859.
   PubMed Web of Science ®Google Scholar
• Yamasaki L, Jacks T, Bronson R, et al. Tumor induction and tissue atrophy in mice lacking e2f-1. Cell. 1996;85(4):537–548.
   PubMed Web of Science ®Google Scholar
• Field SJ, Tsai F-Y, Kuo F, et al. E2f-1 functions in mice to promote apoptosis and suppress proliferation. Cell. 1996;85:549–561.
   PubMed Web of Science ®Google Scholar
• Lee J-S, Leem S-H, Lee S-Y, et al. Expression signature of E2F1 and its associated genes predict superficial to invasive progression of bladder tumors. J clin oncol. 2010;28(16):2660–2667.
   PubMed Web of Science ®Google Scholar
• Jin H, Xie Q, Guo X, et al.P63α protein upregulates heat shock protein 70 expression via e2f1 transcription factor 1, promoting wasf3/wave3/mmp9 signaling and bladder cancer invasion. J Biol Chem. 2017;292(38):15952–15963. jbc. M117.
   PubMed Web of Science ®Google Scholar
• Su N, Qiu H, Chen Y, et al. Mir-205 promotes tumor proliferation and invasion through targeting esrrg in endometrial carcinoma. Oncol Rep. 2013;29(6):2297–2302.
   PubMed Web of Science ®Google Scholar
• Nie G, Duan H, Li X, et al. Microrna‑205 promotes the tumorigenesis of nasopharyngeal carcinoma through targeting tumor protein p53-inducible nuclear protein 1. Mol Med Rep. 2015;12(4):5715–5722.
   PubMed Web of Science ®Google Scholar
• Mitash N, Tiwari S, Agnihotri S, et al. Bladder cancer: micro rnas as biomolecules for prognostication and surveillance. Indian J Urol. 2017;33(2):127–133.
   PubMed Web of Science ®Google Scholar
• Dip N, Reis ST, Timoszczuk LS, et al. Stage, grade and behavior of bladder urothelial carcinoma defined by the microrna expression profile. J Urol. 2012;188(5):1951–1956.
   PubMed Web of Science ®Google Scholar